← All stocks

MIRA PHARMACEUTICALS, INC.

MIRA Net buying
CIK 0001904286 #4898 in the set updated 22 Sep 2026
Bought (120 mo)
$1.94M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.25M
$133.65K on a plan · $0.00 straight out of an exercise
Sold at will
$1.12M
23 of 25 sales
Net
+$689.96K
+$823.61K against sales at will

By person

4 insiders · 35 transactions
10.2×

Erez Aminov holds 10.2 times base salary in stock. $4.48M of shares against $438.75K in salary for 2025.

Salary from the company's own proxy. The shares are what Erez Aminov last reported holding, valued at $1.27, the price Common Stock was last bought or sold at on the open market here, on 20 Nov 2024.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Cappy George
10% owner
$1.93M (2)
+$1.93M
2,859,318
$3.63M
+10.7%
McNulty Brian Patrick
10% owner
$1.12M (23)
−$1.12M
2,540,270
$3.23M
−14.7%
Aminov Erez
Chief Executive Officer
$8.18K (8)
$133.65K (2) scheduled
−$125.47K
3,530,156
$4.48M
+304.1%
Shekhat Denil Nanji
Director
22,378
$28.42K

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 16,560,852 to 42,022,087 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Aminov Erez
20 Nov 2024
Chief Executive Officer
Sold on a plan
44,590
$1.27
$56.63K
Aminov Erez
19 Nov 2024
Chief Executive Officer
Sold on a plan
55,410
$1.39
$77.02K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 2,770,334
History held since 4 Aug 2023